¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Hypothalamic dysfunction, NEC"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • neurogenic vesical dysfunction
    ½Å°æ¼º¹æ±¤±â´ÉÀå¾Ö
  • neuromuscular dysfunction
    ½Å°æ±Ù(À°)±â´ÉÀÌ»ó
  • psychosexual dysfunction
    Á¤½Å¼º¼º±â´ÉÀå¾Ö
  • perceptual dysfunction
    Áö°¢Àå¾Ö
  • sexual dysfunction
    ¼º±â´ÉÀå¾Ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • neuromuscular dysfunction
    ½Å°æ±ÙÀ°±â´ÉÀå¾Ö
  • perceptual dysfunction
    Áö°¢Àå¾Ö
  • sexual dysfunction
    ¼º±â´ÉÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hypothalamic hypogonadism
    ½Ã»óÇϺμº ¼º¼±±â´ÉÀúÇÏÁõ
  • hypothalamic hypophysiotropic hormone
    ½Ã»óÇϺÎ(¼º) Çâ(³ú)Çϼöü¼º È£¸£¸ó .
  • hypothalamic obesity
    ½Ã»óÇϺμº ºñ¸¸(Áõ)(¡­ÝþØ»ñø).
  • hypothalamic osmoreceptor
    ½Ã»óÇϺλïÅõ¼ö¿ë±â.
  • hypothalamic pituitary adrenal axis
    ½Ã»óÇϺÎÇϼöüºÎ½Å°è(ãÊßÉù»Ý»ù»á÷ô÷ Üùãìͧ).
  • hypothalamic pituitary adrenal axis
    ½Ã»óÇϺÎÇϼöü ºÎ½Å°è(ãÊßÉù»Ý»ù»á÷ô÷ Üùãìͧ).
  • hypothalamic pituitary adrenal axis
    ½Ã»óÇϺγúÇϼöüºÎ½Å°è(ãÊßÉù»Ý»Òàù»á÷ô÷Üùãìͧ).
  • hypothalamic pituitary gonadal axis
    ½Ã»óÇϺΠ³úÇϼöü ¼º¼±°è
  • hypothalamic releasing factor
    ½Ã»óÇϺÎÀ¯¸®ÀÎÀÚ(ë¤×ãì×í­).
  • hypothalamic releasing factor
    ½Ã»óÇϺιæÃâÀÎÀÚ.
  • hypothalamic sulcus
    ½Ã»ó¾Æ·¡°í¶û
  • posterior hypothalamic area
    ÈĽûóÇϺΠ¿µ¿ª.
  • posterior hypothalamic nucleus
    µÚ½Ã»óÇϺÎÇÙ
  • posterior hypothalamic region
    ½Ã»óÇϺεڱ¸¿ª
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • neurogenic vesical dysfunction
    ½Å°æÀμº ¹æ±¤±â´ÉºÎÀü
  • neuromuscular dysfunction
    ½Å°æ±Ù ±â´ÉºÎÀü, ¡­±â´ÉÀå¾Ö
  • perceptual disorder =p. dysfunction
    Áö°¢Àå¾Ö(ò±ÊÆî¡äô).
  • placental dysfunction syndrome
    Źݱâ´ÉºÎÀüÁõÈıº(¡­Ñ¦ÒöÝÕîïñøý¦ÏØ).
  • placental dysfunction syndrome
    Źݱâ´ÉºÎÀüÁõÈıº(÷ÃÚïѦÒöÝÕîïñøý¦ÏØ)
  • sexual dysfunction
    ¼º±â´ÉÀå¾Ö
  • sexual dysfunction
    ¼º±â´É°ï¶õ
  • somatoform autonomic dysfunction
    ½ÅüÇü ÀÚÀ²½Å°æ±â´É°ï¶õ
  • tube dysfunction, eustachian
    À̰ü±â´ÉºÎÀü
  • vesical dysfunction
    ¹æ±¤±â´ÉÀÌ»ó
  • voiding dysfunction
    ¹è´¢±â´ÉÀÌ»ó
  • anterior hypothalamic nucleus
    ¾Õ½Ã»óÇϺÎÇÙ
  • anterior hypothalamic region
    ½Ã»óÇϺξձ¸¿ª
  • branches of hypothalamic nucleus
    ½Ã»óÇϺÎÇÙ°¡Áö
  • dorsal hypothalamic nucleus
    µîÂʽûóÇϺÎÇÙ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AHA acetohydroxamic acid; acquired hemolytic anemia; acute hemolytic anemia; American Heart Association;...
AHPO anterior hypothalamic preoptic [area]
CHHS congenital hypothalamic hamartoma syndrome
DMNL dorsomedial hypothalamic nucleus lesion
HA H antigen; Hakim-Adams [syndrome]; halothane anesthesia; Hartley [guinea pig]; headache; health alli...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ETD Eye tracking dysfunction
LVD Left Ventricular Dysfunction
LVSD Left ventricular systolic dysfunction
MGD Meibomian gland dysfunction
MBD Minimal Brain Dysfunction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • mechanical dysfunction
    ±â°èÀû ±â´É Àå¾Ö
  • myofacial pain dysfunction
    ¾È¸é±Ù µ¿Åë ±â´É Àå¾Ö
  • myofascial pain dysfunction syndrome
    ±Ù¸· µ¿Åë ±â´É Àå¾Ö ÁõÈıº, ±Ù¸· ÅëÁõ ±â´ÉÀå¾Ö ÁõÈıº
    µ¿ÀǾî=myofascial
  • nerve dysfunction
    ½Å°æ ±â´É Àå¾Ö
  • neutrophil dysfunction syndrome
    È£Áß±¸ ±â´É Àå¾Ö ÁõÈıº
  • pain-dysfunction syndrome
    µ¿Åë ±â´É Àå¾Ö ÁõÈıº
  • painful dysfunction
    µ¿Åë ±â´ÉÀå¾Ö
  • placental dysfunction syndrome
    ÅÂ¹Ý ±â´É ºÎÀü ÁõÈıº
    ŹÝÀÇ º¯¼º¿¡ ÀÇÇÑ Å¹ÝÀÇ ¿µ¾çÀå¾Ö¿Í Àú»ê¼ÒÁõ. »ó´çÈ÷ ÁøÇàµÈ °æ¿ì¿¡ ¼ÕÅé, ÇǺΠ¹× ÅÂÁö´Â ¼±È²»öÀ¸·Î, Á¦´ë´Â Ȳ·Ï»öÀ¸·Î Âø»öµÈ´Ù.
  • polyglandular dysfunction
    ´Ù¼±¼º ±â´É ÀÌ»ó
  • renal dysfunction
    ½Å ±â´É Àå¾Ö
  • temporomandibular dysfunction sysndrome
    ÃøµÎÇÏ¾Ç ±â´É Àå¾Ö ÁõÈıº
  • temporomandibular joint dysfunction
    ÃøµÎÇϾǰüÀý ±â´É Àå¾Ö, ¾Ç°üÀý ±â´É ÀÌ»ó
    ÃøµÎÇϾǰüÀýÀÇ ºñÁ¤»óÀûÀÌ°í ºÒ¿ÏÀüÇϸç Àå¾Ö°¡ ÀÖ´Â ±â´É.
  • temporomandibular pain-dysfunction syndrome
    ÃøµÎÇÏ¾Ç µ¿Åë Àå¾Ö ÁõÈıº
  • TMJ dysfunction syndrome
    ¾Ç°üÀý ±â´É Àå¾Ö ÁõÈıº, ÃøµÎÇϾǰüÀý Àå¾Ö ÁõÈıº
  • TMJ pain dysfunction syndrome
    ¾Ç°üÀý µ¿Åë ±â´É Àå¾Ö ÁõÈıº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
hypothalamic sulcus A groove in the lateral wall of the third ventricle on either side leading from the interventricular foramen to the aditus ad aqueductum cerebri; the sulcus-demarcated boundary between dorsal thalamus and hypothalamus.
Synonym: sulcus hypothalamicus, Monro's sulcus.
(05 Mar 2000)
dorsal hypothalamic region The portion of the hypothalamus located immediately ventral to the hypothalamic sulcus; contains small nuclei, some of which are associated with the ansa lenticularis and the entopeduncular nucleus.
(05 Mar 2000)
dorsomedial hypothalamic nucleus An aggregation of cells in the middle hypothalamus dorsal to the ventromedial nucleus and bordering the third ventricle.
(12 Dec 1998)
intermediate hypothalamic region The infundibular portion of the hypothalamus, includes the medial tuberal nuclei and portions of the dorsomedial, ventromedial, arcuate (infundibular), posterior and lateral hypothalamic nuclei; located internally in the general area of the infundibulum.
(05 Mar 2000)
lateral hypothalamic area Extends throughout most of the rostrocaudal extent of the hypothalamus lateral to the column of the fornix; includes lateral tuberal nuclei, tuberomamillary nuclei, and diffuse populations of cells.
Synonym: lateral hypothalamic area.
(05 Mar 2000)
lateral hypothalamic region Extends throughout most of the rostrocaudal extent of the hypothalamus lateral to the column of the fornix; includes lateral tuberal nuclei, tuberomamillary nuclei, and diffuse populations of cells.
Synonym: lateral hypothalamic area.
(05 Mar 2000)
papillary muscle dysfunction Impaired function of a papillary muscle, usually due to ischemia or infarction, with resulting incompetence of the mitral valve.
Synonym: papillary muscle syndrome.
(05 Mar 2000)
ventricular dysfunction A condition in which the ventricles of the heart exhibit a decreased functionality.
(12 Dec 1998)
ventricular dysfunction, left A condition in which the left ventricle of the heart exhibits a decreased functionality. This decreased function could lead to congestive heart failure or myocardial infarction, among other cardiovascular diseases. Diagnostic measurements that indicate this condition include a diminished ejection fraction and a depressed level of motility of the left ventricular wall.
(12 Dec 1998)
ventricular dysfunction, right A condition in which the right ventricle of the heart exhibits a decreased functionality. This decreased function could lead to congestive heart failure or myocardial infarction, among other cardiovascular diseases. Diagnostic measurements that indicate this condition include a diminished ejection fraction and a depressed level of motility of the right ventricular wall.
(12 Dec 1998)
phagocyte bactericidal dysfunction Disorders in which phagocytic cells cannot kill ingested bacteria; characterised by frequent recurring infection with formulation of granulomas.
(12 Dec 1998)
phagocyte dysfunction Disorder in which the ability of the phagocyte to engulf and ingest particles may be impaired.
(05 Mar 2000)
phagocytic dysfunction disorders immunodeficiency Suppression in number or function of phagocytic cells such as in chronic granulomatous disease.
Synonym: phagocytic dysfunction disorders immunodeficiency.
Origin: L. Phagedaena, Gr Phago, To eat.
(05 Mar 2000)
phagocytic dysfunction immunodeficiency Suppression in number or function of phagocytic cells such as in chronic granulomatous disease.
Synonym: phagocytic dysfunction disorders immunodeficiency.
Origin: L. Phagedaena, Gr Phago, To eat.
(05 Mar 2000)
minimal brain dysfunction An inability to control behaviour due to difficulty in processing neural stimuli.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á